Universe Pharmaceuticals (UPC) Total Current Liabilities (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Total Current Liabilities data on file, last reported at $13.2 billion in Q3 2025.

• For the quarter ending Q3 2025, Total Current Liabilities fell 35.15% year-over-year to $13.2 billion; the trailing twelve-month figure through Sep 2025 stood at $13.2 billion (down 35.15% YoY), and the FY2025 full-year result was $13.2 billion, down 35.15% from the prior year.
• Total Current Liabilities declined to $13.2 billion in Q3 2025, from $20.3 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $20.3 billion in Q3 2024 to a low of $10.2 million in Q1 2022.
• A 5-year average of $4.2 billion and a median of $17.2 million in 2023 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities sank 100.0% in 2021 and soared 147584.19% in 2024, its largest moves.
• Tracing UPC's Total Current Liabilities over 5 years: stood at $11.2 million in 2021, then increased by 16.83% to $13.1 million in 2022, then climbed by 5.01% to $13.8 million in 2023, then soared by 147584.19% to $20.3 billion in 2024, then slumped by 35.15% to $13.2 billion in 2025.
• Business Quant data shows UPC's Total Current Liabilities at $13.2 billion in Q3 2025, $20.3 billion in Q3 2024, and $20.6 million in Q1 2024.